APLMApollomics Inc. Class A Ordinary Shares
24.33USD+3.12%Mkt Cap: 70.45M $P/E: —3d ago
Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. The comp…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap70.45M $
Enterprise Value49.13M $
Revenue (TTM)8.84M $
Gross Profit8.84M $
Net Income (TTM)-10.94M $
Revenue/Share6.115 USD
Last Price24.33 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees14
CountryUS
SectorFinancial Services
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-36.26
PEG—
EV/EBITDA-5.41
EV/Revenue5.56
P/S7.72
P/B-15.87
EPS (TTM)-7.56
EPS (Forward)-0.65
52W Range
3.65954% of range42.12
52W High42.12 USD
52W Low3.659 USD
Profitability
Gross Margin100.00%
Oper. Margin431.87%
EBITDA Margin-102.75%
Profit Margin-128.69%
ROE343.13%
ROA-162.93%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.37M $
CapEx (TTM)—
FCF Margin-110.93%
FCF Yield-13.92%
Net Debt-2.63M $
Net Debt/EBITDA0.29
Balance Sheet
Debt/Equity-0.20
Current Ratio0.96
Quick Ratio0.91
Book Value/Sh-1.4850 USD
Cash/Share1.492 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateNov 25, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.90M
Float423.86K
Insiders74.12%
Institutions0.52%
Short Interest
Short Ratio0.3d
Short % Float0.60%
Short % Out.0.31%
Shares Short6.73K
Short (prev mo.)5.14K
Technical
SMA 5018.64 (+30.5%)
SMA 20017.46 (+39.3%)
Beta1.45
S&P 52W Chg18.16%
Avg Vol (30d)36.26K
Avg Vol (10d)14.62K
Technical Indicators
RSI (14)69.7
MACD1.2642
MACD Signal0.5073
MACD Hist.+0.7569
BB Upper23.96 USD
BB Middle18.90 USD
BB Lower13.84 USD
BB Width53.56%
ATR (14)1.848 USD
Vol Ratio (20d)0.20x